Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion type Assertion NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_head.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion description "[Both the normal-appearing intestinal mucosa and adenomas obtained from dibenzazepine-treated Apc(Min/+) mice had increased goblet cell numbers and Klf4 staining accompanied by reduced cyclin D1 and Ki-67 staining when compared with those from vehicle-treated mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_provenance.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion evidence source_evidence_literature NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_provenance.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion SIO_000772 19074836 NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_provenance.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion wasDerivedFrom befree-20150227 NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_provenance.
- NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_assertion wasGeneratedBy ECO_0000203 NP260077.RAke9BpKNF_HwB1fE48FegIM7mjeWP8NmjrJxaIDBdng8130_provenance.